ライフサイエンスコーパス: hypopharynx

1 sites: oral tongue, oropharynx, larynx, and hypopharynx.

2 th squamous cell carcinoma of the larynx and hypopharynx.

3 split around the larynx and rejoined in the hypopharynx.

4 f the oral cavity, oropharynx, and larynx or hypopharynx.

5 2 patients were included (397 oropharynx, 53 hypopharynx, 48 larynx, 64 other/unknown primary).

6 %]), oral cavity (61 [28.8%]), and larynx or hypopharynx (52 [24.5%]).

7 pharyngeal area (171 [61.7%]), and larynx or hypopharynx (54 [19.5%]).

8 entation of transverse cine MR images of the hypopharynx aids in quantification of increased airway w

9 tubes are percutaneously placed through the hypopharynx and directed into the stomach or small bowel

10 leading SNP rs142021700) was identified for hypopharynx and larynx cancer risk.

11 low and cough-like expulsive reflexes in the hypopharynx and larynx, respectively.

12 at can arise in the oral cavity, oropharynx, hypopharynx and larynx.

13 Before the 1990s, hypopharynx and oropharynx cancers carried the highest e

14 leading to direct communication between the hypopharynx and the mediastinum.

15 x subjects we also recorded pressures in the hypopharynx and upper oesophagus.

16 stablished cell lines UMUC3 (bladder), FaDu (hypopharynx), and primary cultures of head and neck tumo

17 ll carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx treated with definitive surgery

18 fically the oral cavity, oropharynx, larynx, hypopharynx, and paranasal sinuses, is the seventh most

19 PC, -1.23; 95% CI, -1.84 to -0.62; P = .001; hypopharynx: APC, -2.44; 95% CI, -3.01 to -1.86; P < .00

20 Aspirates from the hypopharynx at age 4 weeks were cultured for Streptococc

21 iration, colored water was perfused into the hypopharynx at the rate of 1 mL/min.

22 volume of water that can safely dwell in the hypopharynx before spilling into the larynx (Hypopharyng

23 inverse associations with risk of larynx and hypopharynx cancer combined (OR 0.55, 95CI% 0.39-0.78) a

24 ed; 37 had base of tongue cancer, and 22 had hypopharynx cancer.

25 ve neck in patients with recurrent larynx or hypopharynx cancers who received total laryngectomy afte

26 etaxel in Patients With T3 and T4 Larynx and Hypopharynx Carcinoma]).

27 by premature spillage of oral fluid into the hypopharynx, delayed clearance of fluid from the hypopha

28 juvant immunotherapy use since 2013 were the hypopharynx (from 0.25% to 1.30%), gums and other oral c

29 low; in Dualula, the siphon base surrounds a hypopharynx housing a small, valved pump constricted to

30 with ENE- and HPV-negative oropharynx (OP), hypopharynx (HP), and larynx cancer (HR, 0.57; 95% CI, 0

31 d squamous cell carcinoma of the oropharynx, hypopharynx, larynx, or oral cavity (unselected for PD-L

32 ral cancers, 135 oropharynx cancers, and 247 hypopharynx/larynx cancers) and 300 patients with esopha

33 obacco-related cancers (larynx, oral cavity, hypopharynx, lung) and an HPV-related cancer (anus).

34 d oral cavity (n = 14), oropharynx (n = 37), hypopharynx (n = 4), larynx (n = 16), and unknown primar

35 ere often seen in the nasopharynx and in the hypopharynx of asymptomatic sleeping children.

36 pharynx, delayed clearance of fluid from the hypopharynx, or excessive hypopharyngeal pressure genera

37 ith LA-HNSCCs of the oral cavity, oropharynx/hypopharynx, or larynx treated with definitive radiother

38 ll carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx undergoing first-line curative tr

39 Patients with LASCCHN of the oropharynx, hypopharynx, or larynx with measurable disease were rand

40 ll established in cancer of the oral cavity, hypopharynx, or larynx, collectively referred as non-OPS

41 wn carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx.

42 ay diameter of the nasopharynx (P <.001) and hypopharynx (P <.001).

43 in the nasopharynx (P <.006) but not in the hypopharynx (P =.655).

44 stage (odds ratio, 3.07; P = .0036); larynx/hypopharynx primary site (odds ratio, 4.17; P = .0041);

45 Older age, advanced T-stage, and larynx/hypopharynx primary site were strong independent risk fa

46 tients and was enriched in oral, larynx, and hypopharynx primary tumors.

47 s and superlinguae between the mandibles and hypopharynx, reinforcing an alliance between euthycarcin

48 The hypopharynx showed dynamic motion in 72 (49%) of the pat

49 : nasopharynx SP (P <.001) and IC (P <.001); hypopharynx SP (P <.001) and IC (P <.001); and mean chan

50 Recurrent hypopharynx subsite was associated with an increased ris

51 d with survival, and patients with recurrent hypopharynx subsite were more likely to have a distant r

52 of the preoral chamber, such as a prominent hypopharynx supported by tentorial bars and superlinguae

53 ecurrent, clinically node-negative larynx or hypopharynx tumors after definitive nonsurgical treatmen

54 UM-SCC-22A cells (squamous cell carcinoma of hypopharynx) via overexpression of mammalian upstream re

55 Motion of the nasopharynx, oropharynx, and hypopharynx was characterized as static patent, dynamic

56 However, collapse of the hypopharynx was not normally encountered.

57 The nasopharynx, oropharynx, and hypopharynx were characterized in terms of airway motion

58 carcinoma of the oral cavity, oropharynx, or hypopharynx were eligible.

59 cavity, oropharynx, nasopharynx, larynx, and hypopharynx were included; any patient whose record was

60 rse fast gradient-echo cine MR images of the hypopharynx were obtained at 1.5 T in 31 children with O

61 f the oropharynx (p16 negative), larynx, and hypopharynx with a Zubrod performance status of 0 to 1 w

62 Colonization of the hypopharynx with M. catarrhalis, S. pneumoniae, H. influ